Oncolytics Biotech (ONCY) Tops Q4 EPS by 10c

Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.05), $0.10 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight